COVID-19 + MRSA Increases Risk for Co-Morbidity
December 15, 2020 12pm
Our webinar will discuss how new genetic tools and methods for MRSA detection are used by a few leading hospitals and healthcare agencies. These organizations are leveraging whole genome sequencing to better identify MRSA hotspots in critical care settings. We will share two of these successful evaluations.
At this critical time during the COVID-19 pandemic, our platform will allow organizations to identify and benchmark the risk of co-morbidity for high-risk patients. Please register by filling out the form below.
Error: cannot render the form without at least one admin email address or a CRM email address.